Cardiovascular Disease: The Other Face of Diabetes

Despite glycemic control, evidence suggests that mortality and morbidity remain high in diabetes. Regulatory agencies deem, therefore, additional safety trials necessary for the approval of new antidiabetic drugs. Nevertheless, markers of cardiovascular risk, which can be used as response predictors...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlasakakis, G, Della Pasqua, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817377/
https://www.ncbi.nlm.nih.gov/pubmed/24153424
http://dx.doi.org/10.1038/psp.2013.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817377/
https://www.ncbi.nlm.nih.gov/pubmed/24153424
http://dx.doi.org/10.1038/psp.2013.57

Ejemplares similares